Effects of Breathing and Walking Treatments on Recovery Post-Spinal Cord Injury
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine (1) if a specific breathing treatment (intermittent hypoxia) can promote changes in breathing function and (2) if pairing breathing treatments (hypoxia) with locomotor training can enhance the benefits of walking recovery observed with locomotor training alone (without breathing treatments).
| Condition | Intervention |
|---|---|
|
Spinal Cord Injuries Brown Sequard Central Cord Syndrome |
Other: Breathing (Hypoxia) Treatment Other: Breathing (Hypoxia) Treatment and Locomotor Training |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Intermittent Hypoxia and Locomotor Training: Effects Following SCI |
- Minute ventilation [ Time Frame: Post-treatment ] [ Designated as safety issue: No ]
- Propulsion generated during stepping [ Time Frame: At the end of the treatment intervention (after 2 weeks) ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 41 |
| Study Start Date: | May 2010 |
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Arm 1
Those exposed to hypoxia with elevated levels of carbon dioxide
|
Other: Breathing (Hypoxia) Treatment
Hypoxia (breathing 1/3 less oxygen than what is present in normal room air) versus non hypoxia will be compared to determine whether respiratory drive can be increased following spinal cord injury.
|
|
Experimental: Arm 2
Those exposed to hypoxia and locomotor training
|
Other: Breathing (Hypoxia) Treatment and Locomotor Training
Comparison of the effect of locomotor training with versus without a breathing (hypoxia) treatment. Individuals will be randomized to receiving hypoxia or normal room air. They will receive either the experimental or placebo comparator (whichever they were randomized to) preceding the locomotor training. All individuals, however, will receive locomotor training.
|
|
Placebo Comparator: Arm 3
Those exposed to a placebo breathing treatment (breathing normal room air rather than hypoxia) and locomotor training
|
Other: Breathing (Hypoxia) Treatment and Locomotor Training
Comparison of the effect of locomotor training with versus without a breathing (hypoxia) treatment. Individuals will be randomized to receiving hypoxia or normal room air. They will receive either the experimental or placebo comparator (whichever they were randomized to) preceding the locomotor training. All individuals, however, will receive locomotor training.
|
Detailed Description:
Spinal cord injury (SCI) is a very disabling health problem. Paralysis and paresis of limb and trunk muscles are major consequences of SCI and result in the inability to walk or difficulty walking. The most commonly stated goal by individuals with SCI during rehabilitation is the desire to walk again. Locomotor training (LT) that uses a body-weight support system and treadmill (BWST) is a task-specific rehabilitation intervention that allows practice of walking at normal speeds while loading the lower extremities, facilitating upright posture, and hip extension. Substantial improvement in ambulation can occur following locomotor training (LT) in individuals with motor incomplete spinal cord injury (iSCI). Despite these advances in activity-dependent rehabilitation, a need exists for defining complementary strategies that further amplify endogenous neuroplasticity. The proposed study will assess the therapeutic potential of (1) a respiratory training intervention (acute intermittent hypoxia, or AIH) on breathing function and (2) a combined locomotor (LT) and respiratory (AIH) training intervention for enhancing walking recovery.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults at least 18 years of age
- At least 12 months post-incomplete spinal cord injury (I-SCI), including but not limited to the following syndromes: Brown Sequard and Central Cord Syndromes
- Upper motor neuron lesion at C3 or below (and above T12, with upper motor neuron signs (i.e. presence of clonus, spasms, and/or hyperreflexia))
- A diagnosis of first time SCI including etiology from trauma, vascular, or orthopedic pathology
- Resting oxygen saturation (SpO2) levels of 95-99%
- Individuals who ambulate independently, with an assistive device, or who can walk when provided manual assistance
- Persons using anti-spasticity medication must maintain stable medication dosage during the study
- Able to give informed consent.
- Medical approval by individual's physician
Exclusion Criteria:
- Current participation in a rehabilitation program/research protocol that could interfere or influence the outcome measures of the current study
- History of congenital SCI (e.g. myelomeningocele, intraspinal neoplasm, Frederich's ataxia) or other degenerative spinal disorders (e.g. spinocerebellar degeneration, syringomyelia) that may complicate the protocol
- Inappropriate or unsafe fit of the harness due to the participant's body size and/or joint contractures or severe spasticity that would prohibit the safe provision of either training modality.
- Severe spasticity that would prohibit the safe provision of training.
- Pregnancy - all women of childbearing age will be required to undergo pregnancy testing prior to enrollment
- Unstable medical condition that could interfere with safety during participation in study (i.e. symptomatic cardiopulmonary complication, osteoporosis, contractures or other significant medical complications that would prohibit or interfere with testing of walking function and training or alter compliance with a training protocol)
Contacts and Locations| Contact: Nicole Tester, PhD | (352) 376-1611 ext 7507 | Nicole.Tester@va.gov |
| Contact: Carolyn Hanson, PhD | (352) 376-1611 ext 5110 | carolyn.hanson@va.gov |
| United States, Florida | |
| North Florida/South Georgia Veterans Health System | Recruiting |
| Gainesville, Florida, United States, 32608 | |
| Contact: Nicole Tester, PhD 352-376-1611 ext 7507 Nicole.Tester@va.gov | |
| Principal Investigator: Nicole Tester, PhD | |
| Principal Investigator: | Nicole Tester, PhD | North Florida/South Georgia Veterans Health System |
More Information
No publications provided
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT01272011 History of Changes |
| Other Study ID Numbers: | B7182-W |
| Study First Received: | January 5, 2011 |
| Last Updated: | January 4, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by Department of Veterans Affairs:
|
Respiration Spinal cord injuries Walking recovery |
Additional relevant MeSH terms:
|
Retinitis Pigmentosa Spinal Cord Injuries Central Cord Syndrome Eye Diseases, Hereditary Eye Diseases Retinal Dystrophies Retinal Degeneration |
Retinal Diseases Genetic Diseases, Inborn Spinal Cord Diseases Central Nervous System Diseases Nervous System Diseases Trauma, Nervous System Wounds and Injuries |
ClinicalTrials.gov processed this record on May 19, 2013